Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapies.

Ilya KisterRyan CurtinJinglan PeiKatherine PerdomoTamar E BaconIryna VoloshynaJoseph KimEthan TardioYogambigai VelmuruguSamantha NyovanieAndrea Valeria CalderonFatoumatta DibbaIgda StanzinMarie I SamanovicPranil RautCatarina RaposoJessica PriestMark CabatinganRyan C WingerMark J MulliganYury PatskovskyGregg J SilvermanMichelle Krogsgaard

Published in: Annals of clinical and translational neurology (2022)

Prior COVID-19 infection is associated with enhanced antibody and cellular post-vaccine responses independent of DMT class and vaccine type. There were no differences in immune responses across race/ethnic groups.

Keyphrases

immune response
end stage renal disease
ejection fraction
newly diagnosed
mass spectrometry
multiple sclerosis
sars cov
prognostic factors
peritoneal dialysis
high glucose
patient reported outcomes
dendritic cells
coronavirus disease
inflammatory response